fbpx
en English
af Afrikaanssq Shqipam አማርኛar العربيةhy Հայերենaz Azərbaycan dilieu Euskarabe Беларуская моваbn বাংলাbs Bosanskibg Българскиca Catalàceb Cebuanony Chichewazh-CN 简体中文zh-TW 繁體中文co Corsuhr Hrvatskics Čeština‎da Dansknl Nederlandsen Englisheo Esperantoet Eestitl Filipinofi Suomifr Françaisfy Fryskgl Galegoka ქართულიde Deutschel Ελληνικάgu ગુજરાતીht Kreyol ayisyenha Harshen Hausahaw Ōlelo Hawaiʻiiw עִבְרִיתhi हिन्दीhmn Hmonghu Magyaris Íslenskaig Igboid Bahasa Indonesiaga Gaeligeit Italianoja 日本語jw Basa Jawakn ಕನ್ನಡkk Қазақ тіліkm ភាសាខ្មែរko 한국어ku كوردی‎ky Кыргызчаlo ພາສາລາວla Latinlv Latviešu valodalt Lietuvių kalbalb Lëtzebuergeschmk Македонски јазикmg Malagasyms Bahasa Melayuml മലയാളംmt Maltesemi Te Reo Māorimr मराठीmn Монголmy ဗမာစာne नेपालीno Norsk bokmålps پښتوfa فارسیpl Polskipt Portuguêspa ਪੰਜਾਬੀro Românăru Русскийsm Samoangd Gàidhligsr Српски језикst Sesothosn Shonasd سنڌيsi සිංහලsk Slovenčinasl Slovenščinaso Afsoomaalies Españolsu Basa Sundasw Kiswahilisv Svenskatg Тоҷикӣta தமிழ்te తెలుగుth ไทยtr Türkçeuk Українськаur اردوuz O‘zbekchavi Tiếng Việtcy Cymraegxh isiXhosayi יידישyo Yorùbázu Zulu

FOR PATIENTS

GET DIRECTIONS

SCHEDULE A CONSULTATION

(512) 324-8060

Cancer Research Month: SBRT Shows Effectiveness for Early-Stage Lung Cancer

 

The American Association for Cancer Research acknowledges May as National Cancer Research Month to recognize high-quality, innovative cancer research and make it a top priority. Through various studies, researchers are able to identify cancer risk factors and evaluate optimal treatment options for cancer patients. One recent study revealed excellent long-term, local control rates for medically […]

 

Learn More

 

 

Brain Tumor Awareness Month: Types of Tumors and Treatment Options

 

According to the American Brain Tumor Association, nearly 700,000 people in the U.S. are living with a brain tumor. May is recognized nationally as Brain Tumor Awareness Month, a period devoted to spreading awareness about brain tumors through community-powered education and providing opportunities to get involved and offer support for those affected by the disease. […]

 

Learn More

 

 

Research Study: Cancer Patients Want Input in Treatment Plans

 

A recent study published in JAMA Oncology explored whether shared decision-making was associated with patient ratings of care quality and physician communication. Researchers gathered data on more than 5,300 patients with colon or lung cancer who participated in the Cancer Care Outcomes Research and Surveillance Consortium study. These patients reported their role in over 10,000 […]

 

Learn More

 

 

Treatment Comparison: Proton Therapy vs. CyberKnife

 

Patients seeking an advanced treatment option for their prostate cancer may compare CyberKnife® and proton therapy. While both are known for their precision and minimal side effects, each targets the tumor differently. CyberKnife technology performs stereotactic body radiation therapy. During treatment, high doses of radiation are delivered to the prostate with sub-millimeter precision, minimizing damage […]

 

Learn More

 

 

Dr. Doug Rivera Talks Metastatic Cancer on KXAN Studio 512

 

Austin CyberKnife medical director and radiation oncologist Dr. Doug Rivera discussed the benefits of CyberKnife® for treating metastatic cancer on KXAN-TV’s “Studio 512.” Watch his segment below to learn more about CyberKnife treatment. This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help […]

 

Learn More

 

 

Study: Metastatic Brain Tumor Patients Under 50 Show Improved Survival Rates with Stereotactic Radiosurgery

 

A recent study published in the official journal of the American Society for Radiation Oncology (ASTRO) found that cancer patients with limited brain metastases who are under 50 years old could benefit from stereotactic radiosurgery (SRS) without whole brain radiation therapy (WBRT).  The study analyzed patient data from the three largest randomized clinical trials of SRS […]

 

Learn More

 

 

Austin CyberKnife Medical Director Dr. Doug Rivera Talks Brain Tumors on KXAN-TV

 

At Austin CyberKnife, brain tumors are a frequently treated disease. Austin CyberKnife medical director Dr. Doug Rivera recently appeared on KXAN-TV’s Studio 512 to discuss brain tumors and the benefits of noninvasive CyberKnife® treatment. Watch the video below to view Dr. Rivera’s interview. This is not intended as medical advice to replace the expertise and […]

 

Learn More

 

 

National Oral, Head, and Neck Cancer Awareness Week: How CyberKnife Can Help

 

Oral, Head, and Neck Cancer Awareness Week 2015 is celebrated nationwide April 12-18.  According to the Head and Neck Cancer Alliance, research has shown that many people do not understand where oral, head and neck cancers develop, what are the causes, and how a diagnosis is determined. This type of cancer arises in the head […]

 

Learn More

 

 

National Cancer Control Month: Knowing Your Risk of Diagnosis

 

Every April, Cancer Control Month highlights advances in the fight against cancer and progress toward effective cancer control. The initiatives of Cancer Control Month aim not only to raise awareness of prevention and screening methods, but also help support those who have been diagnosed and are currently battling the disease. There are several factors that […]

 

Learn More

 

 

Head, Neck and Lung Cancer Screening: Study Shows Coupling Scans Could Improve Early Detection, Survival

 

In a recent study completed by the University of Pittsburgh, researchers discovered that screening for head and neck cancer, in addition to lung cancer for eligible candidates, could improve early detection and survival rates. The study analyzed records of more than 3,500 people enrolled in a lung screening program to determine if these participants had […]

 

Learn More